AbbVie's (ABBV) Skyrizi Gets Nod for Psoriatic Arthritis in EU

Mohit Chouhan November 19, 2021
AbbVie (ABBV) secures approval in the EU for Skyrizi to treat adult patients with active psoriatic arthritis.


Post a Comment

0 Comments